Suppr超能文献

2007 年,印度海得拉巴,对未免疫/部分免疫白喉和/或破伤风的儿童进行破伤风类毒素-白喉(Td)疫苗单剂接种的安全性和免疫原性。

Safety and immunogenicity of single dose of tetanus-diphtheria (Td) vaccine among non/partially immune children against diphtheria and/or tetanus, Hyderabad, India, 2007.

机构信息

Directorate of Health Services, Government of Andhra Pradesh, Hyderabad, India.

出版信息

Vaccine. 2010 Aug 23;28(37):5934-8. doi: 10.1016/j.vaccine.2010.06.047. Epub 2010 Jul 8.

Abstract

In Hyderabad, India, diphtheria is common among children aged 5-19 years. On account of low coverage of diphtheria vaccine boosters recommended under the universal immunization programme, a large proportion of children were susceptible/partially immune against diphtheria and/or tetanus. We evaluated immunogenicity and safety of single dose of indigenously developed tetanus-diphtheria (Td) vaccine (diphtheria-toxoid < or =5 Lf) among 483 school children from Hyderabad aged 7-17 years and susceptible/partially immune against diphtheria and/or tetanus. Serological testing 6 weeks after vaccination indicated that vaccine was highly immunogenic with >96% sero-protected against both antigens. The immune response observed indicated a booster response to previously acquired immunity. Administration of additional dose of Td vaccine to the older school children and replacing the tetanus toxoid vaccine with Td in the school health programme would considerably reduce diphtheria burden in Hyderabad.

摘要

在印度海得拉巴,5 至 19 岁儿童中白喉较为常见。由于普及免疫规划推荐的白喉疫苗加强针覆盖率低,很大一部分儿童对白喉和/或破伤风易感/部分免疫。我们评估了 483 名来自海得拉巴的 7 至 17 岁易感/部分免疫白喉和/或破伤风的学龄儿童单次接种国产破伤风白喉(Td)疫苗(白喉类毒素<或=5Lf)的免疫原性和安全性。接种后 6 周的血清学检测表明,疫苗对白喉和破伤风两种抗原的血清保护率均超过 96%,具有高度免疫原性。观察到的免疫应答表明,这是对先前获得的免疫力的加强反应。为大龄学龄儿童接种额外剂量的 Td 疫苗,并在学校卫生规划中用 Td 疫苗替代破伤风类毒素疫苗,将大大降低海得拉巴的白喉负担。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验